Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6 GBX | +4.35% | +6.19% | -11.76% |
2023 | Mothercare half-year profit jumps as costs fall sharper than revenue | AN |
2023 | AIM WINNERS & LOSERS: RUA Life Science slides after strong week | AN |
Valuation
Fiscal Period: März | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 75.81 | 87.25 | 67.55 | 47.9 | 33.82 | - | - |
Enterprise Value (EV) 1 | 82.71 | 87.25 | 78.55 | 60.8 | 47.12 | 45.57 | 44.32 |
P/E ratio | -0.67 x | -2.72 x | 5.71 x | - | 12 x | 12 x | 12 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 0.13 x | - | 0.93 x | 0.66 x | 0.55 x | 0.57 x | 0.48 x |
EV / Revenue | 0.15 x | - | 1.08 x | 0.83 x | 0.77 x | 0.77 x | 0.63 x |
EV / EBITDA | 5.91 x | - | 6.55 x | 9.08 x | 6.64 x | 5.92 x | 5.47 x |
EV / FCF | -6.89 x | - | 9.82 x | 30.4 x | -94.2 x | 28.5 x | 55.4 x |
FCF Yield | -14.5% | - | 10.2% | 3.29% | -1.06% | 3.51% | 1.81% |
Price to Book | - | - | - | -26.7 x | - | 8.57 x | 5 x |
Nbr of stocks (in thousands) | 340,724 | 562,911 | 562,911 | 562,911 | 563,685 | - | - |
Reference price 2 | 0.2225 | 0.1550 | 0.1200 | 0.0851 | 0.0600 | 0.0600 | 0.0600 |
Announcement Date | 5/24/19 | 7/29/21 | 9/13/22 | 9/22/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 566.3 | - | 72.5 | 73.1 | 61.2 | 59.35 | 70.4 |
EBITDA 1 | 14 | - | 12 | 6.7 | 7.1 | 7.7 | 8.1 |
EBIT 1 | -6.3 | - | 11.1 | 6.2 | 7 | 7 | 7.2 |
Operating Margin | -1.11% | - | 15.31% | 8.48% | 11.44% | 11.79% | 10.23% |
Earnings before Tax (EBT) 1 | -66.6 | - | 11.1 | 2.2 | 3.2 | 3.2 | 3.4 |
Net income 1 | -93.4 | -21.5 | 12.1 | -0.1 | 2.6 | 2.6 | 2.7 |
Net margin | -16.49% | - | 16.69% | -0.14% | 4.25% | 4.38% | 3.84% |
EPS 2 | -0.3310 | -0.0570 | 0.0210 | - | 0.005000 | 0.005000 | 0.005000 |
Free Cash Flow 1 | -12 | - | 8 | 2 | -0.5 | 1.6 | 0.8 |
FCF margin | -2.12% | - | 11.03% | 2.74% | -0.82% | 2.7% | 1.14% |
FCF Conversion (EBITDA) | - | - | 66.67% | 29.85% | - | 20.78% | 9.88% |
FCF Conversion (Net income) | - | - | 66.12% | - | - | 61.54% | 29.63% |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 5/24/19 | 7/29/21 | 9/13/22 | 9/22/23 | - | - | - |
Balance Sheet Analysis
Fiscal Period: März | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | 6.9 | - | 11 | 12.9 | 13.3 | 11.8 | 10.5 |
Net Cash position 1 | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 0.4929 x | - | 0.9167 x | 1.925 x | 1.873 x | 1.526 x | 1.296 x |
Free Cash Flow 1 | -12 | - | 8 | 2 | -0.5 | 1.6 | 0.8 |
ROE (net income / shareholders' equity) | - | - | - | - | 35.6% | 62.9% | 40.3% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | - | -0 | - | 0.0100 | 0.0100 |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | 12.3 | - | 2.9 | 2.3 | 1.7 | 0.2 | 0.2 |
Capex / Sales | 2.17% | - | 4% | 3.15% | 2.78% | 0.34% | 0.28% |
Announcement Date | 5/24/19 | 7/29/21 | 9/13/22 | 9/22/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.76% | 42.13M | |
+4.73% | 143B | |
-28.67% | 45.92B | |
+16.55% | 18.73B | |
+15.45% | 10.64B | |
+27.75% | 8.41B | |
+0.96% | 6.83B | |
-9.08% | 6.41B | |
+29.34% | 6.32B | |
+10.13% | 5.94B |
- Stock Market
- Equities
- MTC Stock
- Financials Mothercare plc